Valuation: Terumo Corporation

Market Cap 3,308B 21.33B 18.47B 17.47B 15.81B 29.68B 2,046B 29.9B 208B 80.19B 1,037B 80.1B 78.33B P/E 2027 *
16.7x
P/E 2028 * 17.2x
Enterprise Value 3,354B 21.62B 18.73B 17.71B 16.03B 30.09B 2,074B 30.32B 211B 81.31B 1,052B 81.22B 79.42B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.45x
Free-Float
97.07%
Yield 2027 *
1.65%
Yield 2028 * 1.81%
1 day+0.07%
1 week-1.06%
Current month-10.81%
1 month-14.35%
3 months+1.08%
6 months+8.17%
Current year-1.15%
1 week 2,194.5
Extreme 2194.5
2,313.5
1 month 2,194.5
Extreme 2194.5
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-1.06%-10.97%+3.77% 21.33B
-1.03%-3.31%-22.31%+0.29% 177B
-0.05%+1.47%+0.34%+14.65% 120B
-0.90%-0.43%+10.94%+81.33% 61.69B
+1.65%+3.81%+0.10%-29.51% 50.64B
+0.27%-3.53%+3.35%+39.11% 48.16B
+2.09%+2.27%+14.38%-10.28% 32.62B
-1.47%-7.44% - - 28.17B
+2.76%+8.07%+41.73%-7.40% 25.69B
-1.58%-3.74%-15.14%-8.37% 20.5B
Average +0.70%-1.47%+2.49%+9.29% 58.53B
Weighted average by Cap. +0.39%-1.33%-3.70%+11.84%

Financials

2027 *2028 *
Net sales 1,259B 8.12B 7.03B 6.65B 6.02B 11.29B 778B 11.38B 79.33B 30.52B 395B 30.48B 29.81B 1,339B 8.63B 7.48B 7.07B 6.4B 12.02B 828B 12.11B 84.39B 32.47B 420B 32.43B 31.71B
Net income 195B 1.26B 1.09B 1.03B 933M 1.75B 121B 1.76B 12.3B 4.73B 61.19B 4.73B 4.62B 192B 1.24B 1.07B 1.01B 918M 1.72B 119B 1.74B 12.1B 4.66B 60.24B 4.65B 4.55B
Net Debt 45.99B 296M 257M 243M 220M 413M 28.44B 416M 2.9B 1.11B 14.42B 1.11B 1.09B -26.39B -170M -147M -139M -126M -237M -16.32B -239M -1.66B -640M -8.28B -639M -625M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
16/09/26 ¥2,244.00 +0.07% 2,879,300
15/09/26 ¥2,242.50 -0.88% 2,588,100
14/09/26 ¥2,262.50 +0.73% 6,110,900
11/09/26 ¥2,246.00 +0.49% 6,580,400
10/09/26 ¥2,235.00 -1.46% 5,919,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,242.50JPY
Average target price
3,110.00JPY
Spread / Average Target
+38.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!